{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T20:06:09Z","timestamp":1783541169826,"version":"3.55.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T00:00:00Z","timestamp":1632787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T00:00:00Z","timestamp":1632787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>There is a paucity of studies investigating the impact of chronic corticosteroid use for coexisting conditions in patients with Coronavirus Disease 2019 (COVID-19). Additionally, the information regarding the impact of chronic liver disease (CLD) on COVID-19 outcomes is evolving. Our study aims to investigate hospitalization outcomes of patients with COVID-19 on long term corticosteroids for coexisting conditions while also seeking to compare outcomes between such patients with a history of CLD to analyze the impact on mortality. We conducted a retrospective chart review across our 10-hospital network identifying patients on chronic corticosteroids (Prednisone\u2009\u2265\u20095\u00a0mg daily dose or equivalent dose of another steroid, for a duration of 30\u00a0days or more) who were hospitalized with COVID-19 from March 1, 2020 to June 30, 2020. Of these patients who met inclusion criteria, patients were then divided into groups based upon their history of CLD. Primary outcomes of the study looked to investigate the hospitalization outcomes of patients with a history of CLD and comorbid conditions requiring chronic corticosteroid use. Secondary outcomes sought to further investigate risk factors for mortality in our study sample. 837 charts were reviewed. 139 patients met inclusion criteria of which 34 patients had a history of CLD. Statistical analysis demonstrated no difference in length of hospital stay but increased ICU admission rate in the CLD group (41.2% vs 23.8%). No statistically significant difference was seen in between the CLD and non-CLD groups in term of complication rates and 28-day mortality. However, chronic corticosteroids patients were found to have higher rates of ICU admission and overall 28-day and ICU mortality in comparison to patients who were not on chronic corticosteroids prior to COVID-19 hospitalization. The larger contributor to COVID-19 severity was likely chronic corticosteroid use rather than CLD and thus chronic corticosteroid use should be limited throughout the COVID-19 pandemic especially in patients with additional speculated risk factors for COVID-19 such as CLD.<\/jats:p>","DOI":"10.1038\/s41598-021-98778-z","type":"journal-article","created":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T10:03:21Z","timestamp":1632823401000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Comparison of the impact of chronic corticosteroid therapy on critical care outcomes of COVID-19 patients with and without history of chronic liver disease"],"prefix":"10.1038","volume":"11","author":[{"given":"Hammad","family":"Liaquat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittney","family":"Shupp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Rollins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yecheskel","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayaz","family":"Matin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,28]]},"reference":[{"issue":"2","key":"98778_CR1","doi-asserted-by":"publisher","first-page":"E15","DOI":"10.1148\/radiol.2020200490","volume":"296","author":"ZY Zu","year":"2020","unstructured":"Zu, Z. Y. et al. Coronavirus disease 2019 (COVID-19): A perspective from China. Radiology 296(2), E15\u2013E25. https:\/\/doi.org\/10.1148\/radiol.2020200490 (2020).","journal-title":"Radiology"},{"key":"98778_CR2","doi-asserted-by":"publisher","first-page":"2402961","DOI":"10.34133\/2020\/2402961","volume":"2020","author":"X Wang","year":"2020","unstructured":"Wang, X. et al. Comorbid chronic diseases and acute organ injuries are strongly correlated with disease severity and mortality among COVID-19 patients: A systemic review and meta-analysis. Research 2020, 2402961. https:\/\/doi.org\/10.34133\/2020\/2402961 (2020).","journal-title":"Research"},{"key":"98778_CR3","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14470","author":"J Sun","year":"2020","unstructured":"Sun, J., Aghemo, A., Forner, A. & Valenti, L. COVID-19 and liver disease. Liver Int. https:\/\/doi.org\/10.1111\/liv.14470 (2020).","journal-title":"Liver Int."},{"key":"98778_CR4","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1053\/j.gastro.2020.04.064","volume":"159","author":"S Singh","year":"2020","unstructured":"Singh, S. & Khan, A. Clinical characteristics and outcomes of coronavirus disease 2019 among patients with preexisting liver disease in the United States: A multicenter research network study. Gastroenterology 159, 768\u2013771 (2020).","journal-title":"Gastroenterology"},{"key":"98778_CR5","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.jhep.2020.05.013","volume":"73","author":"AM Moon","year":"2020","unstructured":"Moon, A. M. et al. High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: preliminary results from an international registry. J. Hepatol. 73, 705\u2013708 (2020).","journal-title":"J. Hepatol."},{"issue":"10223","key":"98778_CR6","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/S0140-6736(20)30317-2","volume":"395","author":"CD Russell","year":"2020","unstructured":"Russell, C. D., Millar, J. E. & Baillie, J. K. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. The Lancet 395(10223), 473\u2013475 (2020).","journal-title":"The Lancet"},{"issue":"3","key":"98778_CR7","doi-asserted-by":"publisher","first-page":"105924","DOI":"10.1016\/j.ijantimicag.2020.105924","volume":"55","author":"CC Lai","year":"2020","unstructured":"Lai, C. C., Shih, T. P., Ko, W. C., Tang, H. J. & Hsueh, P. R. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents 55(3), 105924. https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.105924 (2020).","journal-title":"Int J Antimicrob Agents"},{"key":"98778_CR8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2021436","author":"Group TR","year":"2020","unstructured":"Group TR. Dexamethasone in hospitalized patients with Covid-19-preliminary report. N. Engl. J. Med. https:\/\/doi.org\/10.1056\/NEJMoa2021436 (2020).","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"98778_CR9","doi-asserted-by":"publisher","first-page":"100169","DOI":"10.1016\/j.jhepr.2020.100169","volume":"2","author":"T Boettler","year":"2020","unstructured":"Boettler, T. et al. Impact of COVID-19 on the care of patients with liver disease: EASL-ESCMID position paper after 6 months of the pandemic. JHEP Rep 2(5), 100169. https:\/\/doi.org\/10.1016\/j.jhepr.2020.100169 (2020).","journal-title":"JHEP Rep"},{"issue":"2","key":"98778_CR10","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1053\/j.gastro.2020.05.032","volume":"159","author":"EJ Brenner","year":"2020","unstructured":"Brenner, E. J. et al. Corticosteroids, but not TNF antagonists, are associated with adverse COVID-19 outcomes in patients with inflammatory bowel diseases: Results from an international registry. Gastroenterology 159(2), 481\u2013491 (2020).","journal-title":"Gastroenterology"},{"issue":"7","key":"98778_CR11","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.cgh.2020.09.027","volume":"19","author":"D Kim","year":"2020","unstructured":"Kim, D. et al. Predictors of outcomes of COVID-19 in patients with chronic liver disease: US multi-center study. Clin. Gastroenterol. Hepatol. 19(7), 1469\u20131479 (2020).","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"8","key":"98778_CR12","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/S2468-1253(20)30183-7","volume":"5","author":"LS Belli","year":"2020","unstructured":"Belli, L. S. et al. COVID-19 in liver transplant recipients: Preliminary data from the ELITA\/ELTR registry. Lancet Gastroenterol. Hepatologyl. 5(8), 724\u2013725 (2020).","journal-title":"Lancet Gastroenterol. Hepatologyl."},{"issue":"7","key":"98778_CR13","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S2468-1253(20)30125-4","volume":"5","author":"GJ Webb","year":"2020","unstructured":"Webb, G. J., Moon, A. M., Barnes, E., Barritt, A. S. & Marjot, T. Determining risk factors for mortality in liver transplant patients with COVID-19. Lancet Gastroenterol. Hepatol. 5(7), 643\u2013644 (2020).","journal-title":"Lancet Gastroenterol. Hepatol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98778-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98778-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98778-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T15:58:11Z","timestamp":1670083091000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98778-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,28]]},"references-count":13,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["98778"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-98778-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,28]]},"assertion":[{"value":"10 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19245"}}